ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
06/24/201516:33:16Statement of Changes in Beneficial Ownership (4)
06/24/201516:28:30Statement of Changes in Beneficial Ownership (4)
06/24/201516:21:55Statement of Changes in Beneficial Ownership (4)
06/24/201508:00:00Valeant Pharmaceuticals To Announce 2015 Second Quarter Results...
06/24/201508:00:00Valeant Pharmaceuticals To Announce 2015 Second Quarter Results...
06/23/201509:15:00Valeant and Progenics Announce the Submission of U.S. New Drug...
06/23/201509:15:00Valeant and Progenics Announce the Submission of U.S. New Drug...
06/19/201510:00:02Bill Ackman's Pershing Square is Betting Big on These 4 Companies
06/17/201508:02:35Allergan To Buy Double-Chin Treatment Maker Kythera For $2.1...
06/16/201516:10:37Current Report Filing (8-k)
06/16/201516:02:44Statement of Changes in Beneficial Ownership (4)
06/16/201515:50:30Initial Statement of Beneficial Ownership (3)
06/15/201508:49:35Actavis Changes Name to Allergan After Deal For Botox Maker
06/12/201519:24:30Statement of Changes in Beneficial Ownership (4)
06/11/201514:35:00ValueAct Capital annonce la vente d'actions de Valeant Pharmaceuticals...
06/11/201509:53:00ValueAct Capital Discloses Sale of Shares of Valeant Pharmaceuticals...
06/11/201509:28:00ValueAct Capital Discloses Sale of Shares of Valeant Pharmaceuticals...
06/11/201509:28:00ValueAct Capital Discloses Sale of Shares of Valeant Pharmaceuticals...
06/11/201509:00:00Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief...
06/11/201509:00:00Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief...

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad